HomeLYEL • NASDAQ
add
Lyell Immunopharma Inc
Previous close
$19.12
Day range
$17.34 - $20.87
Year range
$7.65 - $45.00
Market cap
455.65M USD
Avg Volume
115.90K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 6.00K | -45.45% |
Operating expense | 61.48M | -0.44% |
Net income | -140.72M | 26.68% |
Net profit margin | -2.35M | -34.42% |
Earnings per share | — | — |
EBITDA | -59.08M | -4.17% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 247.22M | -33.28% |
Total assets | 340.05M | -30.72% |
Total liabilities | 91.85M | -14.98% |
Total equity | 248.20M | — |
Shares outstanding | 23.31M | — |
Price to book | 1.64 | — |
Return on assets | -41.09% | — |
Return on capital | -45.70% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -140.72M | 26.68% |
Cash from operations | -32.25M | 31.73% |
Cash from investing | -31.36M | -158.62% |
Cash from financing | 222.00K | -49.20% |
Net change in cash | -63.39M | -1,046.18% |
Free cash flow | -7.44M | -31.57% |
About
Founded
2018
Headquarters
Website
Employees
161
